Procter & Gamble Health Limited (PGHL) - Total Assets

Latest as of September 2025: Rs8.94 Billion INR ≈ $96.73 Million USD

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) holds total assets worth Rs8.94 Billion INR (≈ $96.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Procter & Gamble Health Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Procter & Gamble Health Limited - Total Assets Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's total assets have evolved over time, based on quarterly financial data. Explore how much of Procter & Gamble Health Limited's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Procter & Gamble Health Limited - Asset Composition Analysis

Current Asset Composition (December 2024)

Procter & Gamble Health Limited's total assets of Rs8.94 Billion consist of 66.3% current assets and 33.7% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs898.10 Million 23.7%
Accounts Receivable Rs1.47 Billion 18.5%
Inventory Rs1.09 Billion 13.8%
Property, Plant & Equipment Rs1.22 Billion 15.4%
Intangible Assets Rs7.10 Million 0.1%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Procter & Gamble Health Limited (PGHL) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Procter & Gamble Health Limited's current assets represent 66.3% of total assets in 2024, an increase from 48.6% in 2003.
  • Cash Position: Cash and equivalents constituted 23.7% of total assets in 2024, up from 0.3% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
  • Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.

Procter & Gamble Health Limited Competitors by Total Assets

Key competitors of Procter & Gamble Health Limited based on total assets are shown below.

Company Country Total Assets
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥14.18 Billion
SIMCERE PHARMAC. GRP LTD
F:S2P
Germany €14.73 Billion
Curaleaf Holdings Inc.
TO:CURA
Canada CA$2.88 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
China CN¥4.44 Billion
Walvax BioTech
SHE:300142
China CN¥11.13 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion
Renhe Pharmacy Co Ltd
SHE:000650
China CN¥7.93 Billion

Procter & Gamble Health Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.87 3.35 3.59
Quick Ratio 2.30 2.79 2.65
Cash Ratio 1.26 0.00 0.00
Working Capital Rs4.17 Billion Rs5.41 Billion Rs4.24 Billion

Procter & Gamble Health Limited - Advanced Valuation Insights

This section examines the relationship between Procter & Gamble Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 14.25
Latest Market Cap to Assets Ratio 0.14
Asset Growth Rate (YoY) 0.0%
Total Assets Rs7.94 Billion
Market Capitalization $1.13 Billion USD

Valuation Analysis

Below Book Valuation: The market values Procter & Gamble Health Limited's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Procter & Gamble Health Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual total assets of Procter & Gamble Health Limited from 2003 to 2024.

Year Total Assets Change
2024-12-31 Rs7.94 Billion
≈ $85.89 Million
-0.02%
2023-12-31 Rs7.94 Billion
≈ $85.91 Million
-27.86%
2022-12-31 Rs11.01 Billion
≈ $119.09 Million
+23.21%
2021-12-31 Rs8.94 Billion
≈ $96.65 Million
-9.37%
2020-12-31 Rs9.86 Billion
≈ $106.65 Million
-16.17%
2019-12-31 Rs11.76 Billion
≈ $127.22 Million
-33.14%
2018-12-31 Rs17.59 Billion
≈ $190.28 Million
+77.50%
2017-12-31 Rs9.91 Billion
≈ $107.20 Million
+12.28%
2016-12-31 Rs8.83 Billion
≈ $95.47 Million
+12.61%
2015-12-31 Rs7.84 Billion
≈ $84.78 Million
+10.70%
2014-12-31 Rs7.08 Billion
≈ $76.59 Million
+9.19%
2013-12-31 Rs6.49 Billion
≈ $70.14 Million
+9.14%
2012-12-31 Rs5.94 Billion
≈ $64.27 Million
+18.94%
2011-12-31 Rs5.00 Billion
≈ $54.03 Million
+16.20%
2010-12-31 Rs4.30 Billion
≈ $46.50 Million
-24.32%
2009-12-31 Rs5.68 Billion
≈ $61.44 Million
+1.36%
2008-12-31 Rs5.61 Billion
≈ $60.62 Million
+14.50%
2007-12-31 Rs4.90 Billion
≈ $52.94 Million
+2.12%
2006-12-31 Rs4.79 Billion
≈ $51.84 Million
+23.73%
2005-12-31 Rs3.87 Billion
≈ $41.90 Million
+18.48%
2004-12-31 Rs3.27 Billion
≈ $35.36 Million
+17.60%
2003-12-31 Rs2.78 Billion
≈ $30.07 Million
--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic
Market Cap
$1.13 Billion
Rs104.75 Billion INR
Market Cap Rank
#8529 Global
#418 in India
Share Price
Rs6310.50
Change (1 day)
+0.98%
52-Week Range
Rs4778.60 - Rs6581.50
All Time High
Rs6870.36
About

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter … Read more